Φορτώνει......
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review
Coronavirus disease 2019 (COVID-19) is first detected in December 2019 in Wuhan, China which is a new pandemic caused by SARS-COV-2 that has greatly affected the whole world. Bruton tyrosine kinase (BTK) inhibitors are drugs that are used for the management of cancer, and are being repurposed for CO...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Metabol Open |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318668/ https://ncbi.nlm.nih.gov/pubmed/34345815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metop.2021.100116 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|